A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells

E Yeh, M Cunningham, H Arnold, D Chasse… - Nature cell …, 2004 - nature.com
E Yeh, M Cunningham, H Arnold, D Chasse, T Monteith, G Ivaldi, WC Hahn, PT Stukenberg
Nature cell biology, 2004nature.com
The stability of c-Myc is regulated by multiple Ras effector pathways. Phosphorylation at Ser
62 stabilizes c-Myc, whereas subsequent phosphorylation at Thr 58 is required for its
degradation. Here we show that Ser 62 is dephosphorylated by protein phosphatase 2A
(PP2A) before ubiquitination of c-Myc, and that PP2A activity is regulated by the Pin1 prolyl
isomerase. Furthermore, the absence of Pin1 or inhibition of PP2A stabilizes c-Myc. A stable
c-MycT58A mutant that cannot bind Pin1 or be dephosphorylated by PP2A replaces SV40 …
Abstract
The stability of c-Myc is regulated by multiple Ras effector pathways. Phosphorylation at Ser 62 stabilizes c-Myc, whereas subsequent phosphorylation at Thr 58 is required for its degradation. Here we show that Ser 62 is dephosphorylated by protein phosphatase 2A (PP2A) before ubiquitination of c-Myc, and that PP2A activity is regulated by the Pin1 prolyl isomerase. Furthermore, the absence of Pin1 or inhibition of PP2A stabilizes c-Myc. A stable c-MycT58A mutant that cannot bind Pin1 or be dephosphorylated by PP2A replaces SV40 small T antigen in human cell transformation and tumorigenesis assays. Therefore, small T antigen, which inactivates PP2A, exerts its oncogenic potential by preventing dephosphorylation of c-Myc, resulting in c-Myc stabilization. Thus, Ras-dependent signalling cascades ensure transient and self-limiting accumulation of c-Myc, disruption of which contributes to human cell oncogenesis.
nature.com